Salsalate

From Citizendium
Revision as of 20:14, 1 September 2024 by Pat Palmer (talk | contribs) (duplicate ref)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In pharmacology, salsalate, also called salicylsalicylic acid and disalicylic acid, is a medication which is a non-steroidal anti-inflammatory agent. Salsalate is related to acetylsalicylic acid (aspirin), but unlike acetylsalicylic acid, salsalate does not irreversibly inhibit cyclooxygenase and thus is not an anti-platelet agent.

Salsalate may reduce the Glycosylated hemoglobin A1c in patients with diabetes mellitus type 2.[1]

Drug toxicity

Tinnitus may happen, but is unlikely if the total daily dose is 3 grams or less.[1]

Gastrointestinal toxicity is less than with other non-steroidal anti-inflammatory agents.[2][3]

References

  1. 1.0 1.1 Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, Shoelson SE et al. (2010). "The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial.". Ann Intern Med 152 (6): 346-57. DOI:10.1059/0003-4819-152-6-201003160-00004. PMID 20231565. Research Blogging.
  2. Roth S, Bennett R, Caldron P, Hartman R, Mitchell C, Doucette M et al. (1990). "Reduced risk of NSAID gastropathy (GI mucosal toxicity) with nonacetylated salicylate (salsalate): an endoscopic study.". Semin Arthritis Rheum 19 (4 Suppl 2): 11-9. PMID 2181673[e]
  3. Lanza F, Rack MF, Doucette M, Ekholm B, Goldlust B, Wilson R (1989). "An endoscopic comparison of the gastroduodenal injury seen with salsalate and naproxen.". J Rheumatol 16 (12): 1570-4. PMID 2625689[e]